Trade of the Week: GE

Trade of the Week: GE

Stocks rallied sharply last week on better than expected May job numbers. Some of the most beaten down stocks from March saw the biggest gains. Companies like airlines, car manufacturers, and banks saw the most bullish action in the options market. General Electric (GE) is a company that was hit pretty hard in March and […]

Shares of Nio (NIO) Face Heavy Pressure

Shares of Nio (NIO) Face Heavy Pressure

Shares of electric vehicle maker, Nio (NIO) have faced plenty of pressure this year. However, it appears the EV stock has turned a corner after reporting another month of record deliveries. For May 2020, the company delivered 3,436 vehicles.  That included the delivery of 2,685 ES6s and 751 ES8s.  “In May, we achieved record-high monthly […]

Finding Yield When Interest Rates Are At Zero

Finding Yield When Interest Rates Are At Zero

Global pandemics and civil unrest don’t seem to impact stock prices, but it remains challenging to find yield in a world of near-zero interest rates. Central banks are doing everything they can to keep global economies from crashing (which is the main reason stock prices are stable), and the result is that yield can’t be […]

One Easy Formula for a Retirement of Endless Income

One Easy Formula for a Retirement of Endless Income

Many investors buy hot or well-known stocks in the hope that share prices will continue to rise. However, as I was advised many years ago, hope is not a plan. The plan I share with my subscribers derives from conversations I had over several decades with investors who have actually become wealthy by investing in […]

Moderna (MRNA) Given 75% Probability to Develop COVID-19 Vaccine

Moderna (MRNA) Given 75% Probability to Develop COVID-19 Vaccine

Moderna’s (MRNA) stock has given investors heartburn recently. Moderna first announced promising news related to a COVID-19 vaccine in mid-May. After the news sent MRNA skyward, the company announced it would be doing a secondary offering, in an attempt to raise just over $1.3 billion. Then, a few days later, vaccine experts started questioning MRNA’s […]